FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896221618> ?p ?o ?g. }

• W2896221618 endingPage "e192" @default.
• W2896221618 startingPage "e192" @default.
• W2896221618 abstract "Combined radiotherapy and EGFR-targeted therapy regimen is preferred for patients with advanced oral cancer because it improves local cancer control and overall survival (OS) than radiotherapy alone. However, 50% of patients still develop local recurrence because of radioresistance. And some tumors showed radioresistance after inhibiting EGFR and the downstream signalling ERK, AKT,etc. Therefore, this study sought to identify new targets involved in resistance to EGFR-targeted therapy combined with radiotherapy.Endoplasmic reticulum stress (ERS) plays an important role in the regulation of radio- and chemoresistance in many malignancies. In this study, we investigated the role of EGFR and ERS signaling in the radioresistance of oral cancer. EGFR and ERS signalling pathway activation in KBoral carcinoma cells and the constructed corresponding radioresistant KBR cells after irradiation were detected by western blotting and real-time quantitative PCR. The radioresistance ofEGF-EGFR was detected using the colony formation assay. The cell apoptosis was detected by flow cytometry. And Cell proliferation was analysed using a Cell Counting Kit-8 (CCK-8) manufacturer’s protocol. DNA double-strand breaks and autophagy was detected by immunofluorescence. Immunohistochemistry was performed on 51 oral squamous cell carcinoma tissue specimens. The correlation between GRP78 and the prognosis of oral cancer patients was analysed using the Kaplan-Meier method. Herein, we constructed radioresistant oral cancer cells (KBR) and confirmed that EGF induced radioresistance, which could be reversed by silencing EGFR. Moreover, EGF activated radiation-induced ERS signalling PERK/ATF6/IRE1-GRP78 in oral cancer cells, whereas silencing EGFR inhibited the aforementioned functions. And EGF significantly increased the radiation-induced phosphorylation of ERK and AKT, while silencing PERK, IRE1α and ATF6 did not alter this effect. Consistent with others, ERS signalling in parallel with AKT/ERK in downstream of EGFR, and therefore may be targeted in amelioration of EGF-EGFR. In addition, silencing EGFR and the EGFR-targeted inhibitors cetuximab or nimotuzumab could inhibit radiation-induced DNA double-strand break (DSB) repair and autophagy, but increase radiation-induced cell apoptosis. The use of the ERS activators tunicamycin and thapsigargin could counteract this effect. Immunohistochemistry results showed that the ERS chaperone GRP78 was associated with poor prognosis of oral cancer (p < 0.05). These data indicate that inhibition of EGFR could reverse the radioresistance of oral cancer cells by inhibiting radiation-induced activation of ERSsignalling PERK/ATF6/IRE1-GRP78." @default.
• W2896221618 created "2018-10-26" @default.
• W2896221618 creator A5022960460 @default.
• W2896221618 creator A5085061414 @default.
• W2896221618 date "2018-11-01" @default.
• W2896221618 modified "2023-09-26" @default.
• W2896221618 title "Inhibition of EGFR Abrogates Radioresistance in Human Oral Cancer by Inhibiting the Endoplasmic Reticulum Stress Chaperone GRP78" @default.
• W2896221618 doi "https://doi.org/10.1016/j.ijrobp.2018.07.694" @default.
• W2896221618 hasPublicationYear "2018" @default.
• W2896221618 type Work @default.
• W2896221618 sameAs 2896221618 @default.
• W2896221618 citedByCount "0" @default.
• W2896221618 crossrefType "journal-article" @default.
• W2896221618 hasAuthorship W2896221618A5022960460 @default.
• W2896221618 hasAuthorship W2896221618A5085061414 @default.
• W2896221618 hasConcept C121608353 @default.
• W2896221618 hasConcept C126322002 @default.
• W2896221618 hasConcept C190283241 @default.
• W2896221618 hasConcept C206684579 @default.
• W2896221618 hasConcept C502942594 @default.
• W2896221618 hasConcept C509974204 @default.
• W2896221618 hasConcept C55493867 @default.
• W2896221618 hasConcept C58962609 @default.
• W2896221618 hasConcept C71924100 @default.
• W2896221618 hasConcept C75217442 @default.
• W2896221618 hasConcept C86803240 @default.
• W2896221618 hasConcept C96232424 @default.
• W2896221618 hasConceptScore W2896221618C121608353 @default.
• W2896221618 hasConceptScore W2896221618C126322002 @default.
• W2896221618 hasConceptScore W2896221618C190283241 @default.
• W2896221618 hasConceptScore W2896221618C206684579 @default.
• W2896221618 hasConceptScore W2896221618C502942594 @default.
• W2896221618 hasConceptScore W2896221618C509974204 @default.
• W2896221618 hasConceptScore W2896221618C55493867 @default.
• W2896221618 hasConceptScore W2896221618C58962609 @default.
• W2896221618 hasConceptScore W2896221618C71924100 @default.
• W2896221618 hasConceptScore W2896221618C75217442 @default.
• W2896221618 hasConceptScore W2896221618C86803240 @default.
• W2896221618 hasConceptScore W2896221618C96232424 @default.
• W2896221618 hasIssue "3" @default.
• W2896221618 hasLocation W28962216181 @default.
• W2896221618 hasOpenAccess W2896221618 @default.
• W2896221618 hasPrimaryLocation W28962216181 @default.
• W2896221618 hasRelatedWork W1991796693 @default.
• W2896221618 hasRelatedWork W2293267168 @default.
• W2896221618 hasRelatedWork W2315718826 @default.
• W2896221618 hasRelatedWork W2363685873 @default.
• W2896221618 hasRelatedWork W2511845891 @default.
• W2896221618 hasRelatedWork W2897358322 @default.
• W2896221618 hasRelatedWork W3028727189 @default.
• W2896221618 hasRelatedWork W4313279980 @default.
• W2896221618 hasRelatedWork W4320065228 @default.
• W2896221618 hasRelatedWork W2892891728 @default.
• W2896221618 hasVolume "102" @default.
• W2896221618 isParatext "false" @default.
• W2896221618 isRetracted "false" @default.
• W2896221618 magId "2896221618" @default.
• W2896221618 workType "article" @default.